Literature DB >> 16716328

Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals.

Nobukazu Ishizaka1, Yuko Ishizaka, Ei-Ichi Toda, Hideki Hashimoto, Ryozo Nagai, Minoru Yamakado.   

Abstract

Hyperuricemia is postulated to be a risk factor for atherosclerotic diseases, although whether it is independent of classical atherogenic risk factors is controversial. The automatic computer-assisted measurement of brachial-ankle pulse wave velocity (baPWV) is a valid and reproducible method by which to assess arterial stiffness, a potential surrogate marker of early atherosclerosis. By analyzing cross-sectional data from 982 individuals who underwent health screening, we have investigated whether serum uric acid is associated with high baPWV, which was determined as the highest quartile of baPWV values, in a sex-specific manner. Multivariate analysis showed that the odds ratios (95% CI) of the highest baPWV quartile across the sex-specific quartiles of serum uric acid were 1.0, 2.80 (0.93-8.40), 2.13 (0.74-6.19), and 2.76 (1.01-7.55) in women, and 1.0, 1.10 (0.55-2.20), 1.97 (1.04-3.75), and 2.24 (1.10-4.56) in men after adjusting for age, total and HDL-cholesterol, BMI, systolic blood pressure, triglycerides, fasting glucose and smoking status. The association between uric acid and high baPWV was observed in both subjects with metabolic syndrome and those without. These data suggest that in both genders, serum uric acid level is associated with increased baPWV, a marker of arterial stiffness, and is in part independent of other conventional risk factors for atherosclerosis and metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716328     DOI: 10.1016/j.atherosclerosis.2006.04.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

Review 1.  Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.

Authors:  Kunal Chaudhary; Kunal Malhotra; James Sowers; Annayya Aroor
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

2.  Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China.

Authors:  Y Lin; X Lai; G Chen; Y Xu; B Huang; Y Wu; Z Chen; L Yao; F Lin; Y Qiao; Z Chen; S Zhu; H Huang; J Wen
Journal:  J Endocrinol Invest       Date:  2011-05-30       Impact factor: 4.256

3.  Presence of tophi is a predictive factor of arterial stiffness in patients with gout.

Authors:  WooSeong Jeong; Seung-Jae Joo; Jinsoek Kim; Jae-Geun Lee; Joon Hyouk Choi
Journal:  Rheumatol Int       Date:  2019-06-01       Impact factor: 2.631

4.  Factors associated with early platelet activation in obese children.

Authors:  Anel Gómez García; Guillermina García Núñez; Martha Eva Viveros Sandoval; Sergio Gutierrez Castellanos; Cleto Alvarez Aguilar
Journal:  Clin Med Res       Date:  2014-01-10

Review 5.  Hyperuricemia and renal risk.

Authors:  Francesca Viazzi; Giovanna Leoncini; Elena Ratto; Roberto Pontremoli
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-31

6.  Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure.

Authors:  Pai-Feng Hsu; Shao-Yuan Chuang; Hao-Min Cheng; Shih-Hsien Sung; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  Int J Cardiol       Date:  2013-02-27       Impact factor: 4.164

7.  Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model.

Authors:  Hongchao Zheng; Ning Li; Yueyou Ding; Peizhi Miao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Relationship between serum uric Acid levels, metabolic syndrome, and arterial stiffness in korean.

Authors:  Ji Hyon Lim; Young-Kwon Kim; Yong-Seok Kim; Sang-Hoon Na; Moo-Yong Rhee; Myoung-Mook Lee
Journal:  Korean Circ J       Date:  2010-07-26       Impact factor: 3.243

Review 9.  The Impacts of Serum Uric Acid on arterial hemodynamics and Cardiovascular Risks.

Authors:  Pai-Feng Hsu; Shao-Yuan Chuang; Wen-Chung Yu; Hsin-Bang Leu; Wan-Leong Chan; Chen-Huan Chen
Journal:  Acta Cardiol Sin       Date:  2013-03       Impact factor: 2.672

10.  Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome.

Authors:  Omer Yiginer; Fatih Ozcelik; Tugrul Inanc; Mustafa Aparci; Namik Ozmen; Bekir Yilmaz Cingozbay; Ejder Kardesoglu; Selami Suleymanoglu; Goksel Sener; Bekir Sitki Cebeci
Journal:  Clin Res Cardiol       Date:  2007-12-28       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.